Stratos Wealth Advisors, LLC Novartis Ag Transaction History

Stratos Wealth Advisors, LLC

$2.13 Billion
Q3 2024

A detailed history of Stratos Wealth Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Stratos Wealth Advisors, LLC holds 8,434 shares of NVS stock, worth $830,327. This represents 0.05% of its overall portfolio holdings.

Number of Shares

8,434

Previous 8,429 0.06%

Holding current value

$830,327

Previous $897,000 8.14%

% of portfolio

0.05%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$106.13 - $120.89 $530 - $604	5 Added 0.06%	8,434 $970,000
Q2 2024 Jul 24, 2024	BUY	$92.57 - $107.37 $1,758 - $2,040	19 Added 0.23%	8,429 $897,000
Q1 2024 Apr 16, 2024	SELL	$95.27 - $108.47 $23,531 - $26,792	-247 Reduced 2.85%	8,410 $813,000
Q4 2023 Jan 24, 2024	BUY	$92.27 - $101.54 $17,623 - $19,394	191 Added 2.26%	8,657 $874,000
Q3 2023 Oct 24, 2023	BUY	$94.73 - $105.13 $34,102 - $37,846	360 Added 4.44%	8,466 $862,000
Q2 2023 Jul 18, 2023	BUY	$92.52 - $104.91 $23,130 - $26,227	250 Added 3.18%	8,106 $817,000
Q1 2023 Apr 27, 2023	SELL	$80.03 - $92.81 $3,601 - $4,176	-45 Reduced 0.57%	7,856 $722,000
Q4 2022 Jan 19, 2023	BUY	$75.55 - $92.52 $596,920 - $731,000	7,901 New	7,901 $0
Q1 2022 Apr 26, 2022	SELL	$80.11 - $90.62 $531,529 - $601,263	-6,635 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$79.7 - $88.13 $27,815 - $30,757	349 Added 5.55%	6,635 $580,000
Q3 2021 Oct 19, 2021	BUY	$81.78 - $95.14 $232,664 - $270,673	2,845 Added 82.68%	6,286 $514,000
Q2 2021 Jul 19, 2021	BUY	$85.24 - $94.15 $293,310 - $323,970	3,441 New	3,441 $314,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Advisors, LLC with notifications on news.

Account

Stratos Wealth Advisors, LLC Novartis Ag Transaction History